# DYNC1LI1

## Overview
The DYNC1LI1 gene encodes the dynein cytoplasmic 1 light intermediate chain 1 (LIC1), a pivotal component of the cytoplasmic dynein motor complex. This protein is integral to the intracellular transport system, facilitating retrograde movement along microtubules in eukaryotic cells. As a part of the dynein complex, LIC1 plays a crucial role in various cellular processes, including autophagy, endocytic trafficking, and mitosis, by interacting with multiple cargo adaptors and effectors (Johnson2024Regulation; Lee2018A). The protein's structure, characterized by an N-terminal GTPase-like domain and a C-terminal region with conserved α-helical segments, allows it to bind tightly to the dynein heavy chain and other effectors, thereby influencing dynein's motility and cargo specificity (Lee2018A; Celestino2019A). DYNC1LI1's involvement in critical cellular functions underscores its significance in maintaining cellular homeostasis and its potential implications in diseases such as cancer and hearing loss (Chang2020Association; Zhang2022Dync1li1).

## Structure
The DYNC1LI1 gene encodes a component of the cytoplasmic dynein complex, specifically the dynein light intermediate chain 1 (LIC1). LIC1 is part of a multi-subunit motor protein complex responsible for intracellular transport. The protein structure includes an N-terminal GTPase-like domain that binds tightly to the dynein heavy chain (DHC) and a C-terminal region that is intrinsically disordered but contains two conserved α-helical segments, known as Helix-1 and Helix-2 (Lee2018A; Zhang2022Dync1li1; Celestino2019A).

Helix-1, located in the C-terminal region, is crucial for binding to various dynein-dynactin effectors, such as Hook1/3, BICD2, and Spindly. This interaction is essential for dynein's processive motility and involves a conserved hydrophobic cleft in the effector proteins (Lee2018A; Celestino2019A). The LIC1 Helix-1 is an amphipathic α-helix, with key hydrophobic residues like L444, F447, F448, and L451 playing a significant role in binding (Lee2018A).

The LIC1 protein can form dimers with a 2:2 stoichiometry when interacting with effectors, which may influence the formation of dynein-dynactin-effector complexes with varying affinities and run lengths (Lee2018A). The presence of splice variants and potential post-translational modifications, such as phosphorylation, may further modulate its function.

## Function
The human gene DYNC1LI1 encodes the dynein cytoplasmic 1 light intermediate chain 1 (LIC1), a core component of the dynein motor complex. This complex is essential for retrograde transport along microtubules in eukaryotic cells, facilitating the movement of organelles, vesicles, and proteins within the cell (Johnson2024Regulation). In healthy cells, LIC1 is involved in the transportation of autophagosomes to lysosomes, a critical process for autophagy and cellular homeostasis. This function is particularly important in cochlear hair cells, where it prevents the accumulation of autophagosomes and subsequent apoptosis, thereby maintaining hearing function (Zhang2022Dync1li1).

LIC1 also plays a significant role in endocytic trafficking, particularly in the regulation of angiogenesis. It interacts with various cargo adaptors to mediate Rab-mediated endosomal recycling and lysosomal degradation. This process is crucial for the proper targeting and degradation of signaling receptors, such as VEGFR2, thereby limiting angiogenic sprouting and maintaining vascular patterning (Johnson2024Regulation). The protein is active in the cytoplasm and is involved in processes like mitosis, vesicular cargo binding, and the maturation of lysosomes and late endosomes (Johnson2024Regulation).

## Clinical Significance
DYNC1LI1 is implicated in various cancers, including colorectal cancer (CRC), where its expression levels are associated with tumor progression and chemoresistance. Increased expression of DYNC1LI1 is observed in metastatic CRC tissues compared to non-metastatic ones, suggesting a role in cancer progression (Chang2020Association). Knockdown of DYNC1LI1 in CRC cell lines results in altered mucin expression and increased sensitivity to chemotherapeutic agents like 5-fluorouracil and oxaliplatin, indicating its potential involvement in chemoresistance mechanisms (Chang2020Association). 

DYNC1LI1 is also part of a gene panel with high diagnostic accuracy for CRC, highlighting its potential as a prognostic marker (Chen2023Potential). In addition to its role in cancer, DYNC1LI1 is crucial for the survival of cochlear hair cells by regulating autophagosome transport. Knockout studies in mice show that loss of DYNC1LI1 leads to progressive hearing loss due to hair cell apoptosis, underscoring its importance in auditory function (Zhang2022Dync1li1). These findings suggest that DYNC1LI1 mutations or dysregulation can contribute to both cancer progression and hearing loss.

## Interactions
The DYNC1LI1 gene encodes the dynein light intermediate chain 1 (LIC1), which is a crucial component of the cytoplasmic dynein motor complex. LIC1 interacts with various dynein-dynactin effectors, which are essential for the processive motility of the dynein motor complex. These interactions occur primarily through a conserved helix in the C-terminal region of LIC1, known as Helix-1 or the Effector-Binding Helix (EBH). This helix binds to the Hook domain of Hook-family effectors, such as Hook1 and Hook3, as well as to coiled-coil segments in CC1-Box-containing effectors like BICD2 and Spindly (Lee2018A).

The interaction between LIC1 and these effectors is characterized by low micromolar affinities and involves a conformational change in the Hook domain, which forms a V-shaped hydrophobic cleft to accommodate LIC1 Helix-1 (Lee2018A). These interactions are crucial for dynein's functional diversity, including cargo specificity and processivity, and are necessary for the activation of dynein processivity by facilitating a conformational change from an auto-inhibited state to a 'parallel-heads' state (Lee2018A).

Additionally, LIC1 binds directly to Rab effector proteins such as FIP3, RILP, and BicD2, which are involved in membrane transport. These interactions occur primarily through the C-terminal domain of LIC1 (Schroeder2014A).


## References


[1. (Zhang2022Dync1li1) Yuan Zhang, Shasha Zhang, Han Zhou, Xiangyu Ma, Leilei Wu, Mengyao Tian, Siyu Li, Xiaoyun Qian, Xia Gao, and Renjie Chai. Dync1li1 is required for the survival of mammalian cochlear hair cells by regulating the transportation of autophagosomes. PLOS Genetics, 18(6):e1010232, June 2022. URL: http://dx.doi.org/10.1371/journal.pgen.1010232, doi:10.1371/journal.pgen.1010232. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1010232)

[2. (Celestino2019A) Ricardo Celestino, Morkos A. Henen, José B. Gama, Cátia Carvalho, Maxwell McCabe, Daniel J. Barbosa, Alexandra Born, Parker J. Nichols, Ana X. Carvalho, Reto Gassmann, and Beat Vögeli. A transient helix in the disordered region of dynein light intermediate chain links the motor to structurally diverse adaptors for cargo transport. PLOS Biology, 17(1):e3000100, January 2019. URL: http://dx.doi.org/10.1371/journal.pbio.3000100, doi:10.1371/journal.pbio.3000100. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.3000100)

3. (Johnson2024Regulation) Regulation of angiogenesis by endocytic trafficking mediated by cytoplasmic dynein 1 light intermediate chain 1. This article has 0 citations.

[4. (Chang2020Association) Chun‑Chao Chang, Kuo‑Ching Chao, Chi‑Jung Huang, Chih‑Sheng Hung, and Yen‑Chieh Wang. Association between aberrant dynein cytoplasmic�1 light intermediate chain�1 expression levels, mucins and chemosensitivity in colorectal cancer. Molecular Medicine Reports, April 2020. URL: http://dx.doi.org/10.3892/mmr.2020.11086, doi:10.3892/mmr.2020.11086. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2020.11086)

[5. (Schroeder2014A) Courtney M Schroeder, Jonathan ML Ostrem, Nicholas T Hertz, and Ronald D Vale. A ras-like domain in the light intermediate chain bridges the dynein motor to a cargo-binding region. eLife, October 2014. URL: http://dx.doi.org/10.7554/elife.03351, doi:10.7554/elife.03351. This article has 83 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.03351)

[6. (Chen2023Potential) Yu-Nung Chen, Cheng-Yen Shih, Shu-Lin Guo, Chih-Yi Liu, Ming-Hung Shen, Shih-Chang Chang, Wei-Chi Ku, Chi-Cheng Huang, and Chi-Jung Huang. Potential prognostic and predictive value of ube2n, impdh1, dync1li1 and hrasls2 in colorectal cancer stool specimens. Biomedical Reports, February 2023. URL: http://dx.doi.org/10.3892/br.2023.1604, doi:10.3892/br.2023.1604. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/br.2023.1604)

[7. (Lee2018A) In-Gyun Lee, Mara A. Olenick, Malgorzata Boczkowska, Clara Franzini-Armstrong, Erika L. F. Holzbaur, and Roberto Dominguez. A conserved interaction of the dynein light intermediate chain with dynein-dynactin effectors necessary for processivity. Nature Communications, March 2018. URL: http://dx.doi.org/10.1038/s41467-018-03412-8, doi:10.1038/s41467-018-03412-8. This article has 85 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-03412-8)